Ahmed Abd-Rabou | Nanobiotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Ahmed Abd-Rabou | Nanobiotechnology | Best Researcher Award

Associate Professor at National Research Centre, Egypt

Dr. Ahmed A. Abd-Rabou is a distinguished Associate Professor of Medical Biochemistry at the National Research Centre (NRC), Egypt, with a robust portfolio in medical sciences, nanotechnology, and cancer biology. His scholarly achievements have been recognized through multiple national and international awards. He earned his Ph.D. in Biochemistry from Cairo University, with academic endorsement from the University of Rostock in Germany and the University of Hong Kong, reflecting his international academic engagement. Dr. Abd-Rabou’s postdoctoral research at INSERM in France and his fellowship at ACPHS in the USA are a testament to his global scientific contributions, particularly in molecular therapeutics and nano-drug delivery systems. With an H-index of 23, his research has significantly advanced the understanding of apoptosis in cancer and stem cell-based therapies.

Profile

Scopus

Education

Dr. Abd-Rabou began his academic journey with a B.Sc. in Biochemistry and Chemistry from Ain Shams University in 2007, graduating with honors and top rank in his class. He pursued his M.Sc. in Biochemistry and Molecular Biology at Cairo University, completed in 2011, and further advanced to a Ph.D. in the same field in 2015. His doctoral work was validated by prominent global institutions, including Rostock University and the University of Hong Kong, and examined by renowned figures such as Prof. Nadia Zakhary and Prof. Josef Brock. These achievements laid a solid foundation for his continued impact in biomedical research.

Experience

Dr. Abd-Rabou has held numerous positions at the NRC since 2008, ascending from Specialist to his current role as Associate Professor. He has been actively involved in auditing and research oversight, serving on the Medical Division Internal Audit ISO team and the Hormones Department Board. His roles include being a core member of the Stem Cell Laboratory at the Advanced Centre of Medical Research and participating in several collaborative initiatives. Internationally, he completed a postdoctoral fellowship at INSERM in France (2016) and a fellowship in nano-drug delivery at ACPHS, New York (2013–2014), strengthening his expertise in nanomedicine and cancer therapeutics.

Research Interest

Dr. Abd-Rabou’s research is focused on medical biochemistry, with particular emphasis on apoptosis, cancer therapy, nanotechnology, and stem cell applications. His work explores molecular mechanisms of drug resistance in cancer, the role of TRAIL and thymoquinone in apoptosis, and mesenchymal stem cells’ therapeutic potential in neurological disorders. His interdisciplinary approach integrates nanotechnology with molecular biology, aiming to design targeted treatments that address the limitations of conventional therapies.

Awards

Dr. Abd-Rabou has received several prestigious awards that highlight his excellence in research. In 2023, he was honored with the National Prize of Excellence in Medical Science, a testament to his influence in the field. He previously earned the NRC Prize for Nanotechnology and Biological Applications in 2019 and the NRC Award for Highest Publications in 2016. His academic excellence was also recognized by the Egyptian Ministry of Defense during his B.Sc. and M.Sc. studies. These accolades underscore his sustained contributions to scientific advancement and innovation in biomedical sciences.

Publications

Dr. Abd-Rabou has published extensively in peer-reviewed journals, with impactful research cited globally. Selected publications include:

  1. Ahmed A. Abd-Rabou et al. (2022). “TRAIL-loaded nanoparticles overcome breast cancer drug resistance via apoptosis induction.” Biomaterials Science. Cited by 45 articles.
  2. Ahmed A. Abd-Rabou et al. (2021). “Stem cell-based therapy in temporal lobe epilepsy models.” Cellular and Molecular Neurobiology. Cited by 28 articles.
  3. Ahmed A. Abd-Rabou et al. (2020). “Nanomedicine approaches in tumor microenvironment modulation.” International Journal of Nanomedicine. Cited by 53 articles.
  4. Ahmed A. Abd-Rabou et al. (2019). “Role of thymoquinone in cancer apoptosis pathways.” Journal of Biochemical Pharmacology. Cited by 61 articles.
  5. Ahmed A. Abd-Rabou et al. (2018). “Molecular markers of breast cancer stemness.” Journal of Cellular Physiology. Cited by 36 articles.
  6. Ahmed A. Abd-Rabou et al. (2017). “Nanotechnology in targeting cancer stem cells.” Cancer Letters. Cited by 48 articles.
  7. Ahmed A. Abd-Rabou et al. (2016). “Functionalization of TNF-Related Ligands in Cancer Nanotherapy.” European Journal of Pharmaceutical Sciences. Cited by 52 articles.

Conclusion

Dr. Ahmed A. Abd-Rabou is an exemplary candidate for prestigious research recognition due to his unwavering commitment to advancing medical biochemistry. His academic and professional journey reflects a deep dedication to integrating cutting-edge nanotechnology with therapeutic strategies against cancer and neurological diseases. His ability to bridge international research standards, supervise future scientists, and contribute meaningfully to national and global health innovations positions him as a leader in the scientific community. Through his diverse roles and impactful publications, Dr. Abd-Rabou has consistently demonstrated excellence, innovation, and a drive for translational research that benefits society at large.

Yinli Zhang | Epigenetics | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Yinli Zhang | Epigenetics | Best Researcher Award

Associate Researcher at Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China

Dr. Yinli Zhang is an Associate Research Fellow and Master Supervisor at the Biomedical Research Center of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University. Her research career is distinguished by focused contributions in reproductive biology, particularly in oogenesis and early embryonic development. With a background in cell biology and biotechnology, Dr. Zhang integrates molecular and epigenetic tools to investigate the cellular mechanisms underlying female infertility. She actively mentors graduate students and contributes to China’s leading research efforts in biomedical science.

Profile

Scopus

Education

Dr. Zhang began her academic journey at Shandong Normal University, earning her Bachelor of Science degree in Biological Technology in 2011. She furthered her studies at Zhejiang University, where she completed her Ph.D. in Cell Biology in 2016. Her doctoral research provided a foundation for her continued interest in reproductive cell dynamics and epigenetic regulation, which has shaped her scientific career and led to her current leadership roles in biomedical research.

Experience

Following her Ph.D., Dr. Zhang joined the Sir Run Run Shaw Hospital at Zhejiang University as an Assistant Researcher in 2016. She advanced to a specially appointed Associate Researcher role in 2020 and has held the position of Associate Research Fellow since January 2024. Her institutional affiliation has allowed her to spearhead independent research projects while collaborating with multidisciplinary teams. Through her roles, she has contributed to numerous national-level studies and guided young researchers in translational medicine and developmental biology.

Research Interest

Dr. Zhang’s primary research interests center on basic mechanisms regulating oogenesis and early embryonic development. She is particularly focused on investigating the genetic and epigenetic factors contributing to refractory female infertility. Her research explores molecular pathways that regulate chromatin remodeling, histone modifications, and oocyte aging. Her projects employ cutting-edge techniques such as single-cell sequencing, CRISPR gene editing, and transcriptomic analysis to elucidate the roles of ubiquitin ligases, histone modifiers, and RNA-binding proteins in early development.

Award

Throughout her career, Dr. Zhang has received national-level recognition for her scientific leadership. She has been the principal investigator for competitive grants funded by the National Natural Science Foundation of China and the National Key R&D Program. These honors reflect her contributions to improving the understanding and potential treatments of infertility-related disorders. Her work has also earned her invitations to participate in professional societies such as the Chinese Association for Physiological Sciences and the Germ Cell Professional Committee of Zhejiang.

Publication

Dr. Zhang has contributed to several influential scientific journals. Below are seven selected publications:

  1. Ma Y, Zhang Y#, Yang W#, et al. (2025). “The Nuclear Localization of ACLY Guards Early Embryo Development…” Advanced Science – Widely cited for its insights on histone acetylation in embryos.
  2. Ren P, Tong X, Li J, et al. (2024). “CRL4 DCAF13 E3 ubiquitin ligase targets MeCP2…” Cell Mol Life Sci – Explores transcription regulation in oocytes.
  3. Jin J, Ren P, Li X, et al. (2023). “Ovulatory signal-triggered chromatin remodeling…” Epigenetics Chromatin – A significant study in granulosa cell epigenetics.
  4. Zhang YY, Yang W, Zhang Y, et al. (2023). “HucMSC-EVs Facilitate In Vitro Development…” Stem Cell Rev Rep – Innovative work in aged follicle development.
  5. Tong X, Jin J, Hu Z, Zhang Y, et al. (2022). “Mutations in OOEP and NLRP5…” Human Mutation – Noted for identifying causes of embryonic arrest.
  6. Zhang YL, Zheng W, Ren P, et al. (2021). “Biallelic mutations in MOS cause female infertility…” EMBO Mol Med – Highly cited in the field of reproductive genetics.
  7. Ma Y, Yang W, Ren P, et al. (2021). “Lysophosphatidic acid improves oocyte quality…” Mol Hum Reprod – Focused on pathways enhancing oocyte maturation.

Conclusion

Dr. Yinli Zhang exemplifies scientific dedication through her pioneering research in reproductive biology and infertility mechanisms. Her career reflects a balance of academic excellence, mentorship, and innovation. By translating basic science into potential therapeutic targets, Dr. Zhang continues to contribute meaningfully to the advancement of women’s reproductive health. With a prolific publication record and successful management of national research projects, she remains a key contributor to the biomedical sciences community in China and internationally.

 

Daria Maria Monti | Biochemistry | Best Academic Researcher Award

Published on by Biotechnology Scientist

Prof. Daria Maria Monti | biochemistry | Best Academic Researcher Award

Associate Professor at University of Naples Federico II, Italy

Daria Maria Monti (DMM) is an accomplished Associate Professor in the Department of Chemical Sciences at the University of Naples Federico II, with an impressive track record in cellular biology and biochemistry. She is widely recognized for her investigations into the cytotoxic effects of noble metal compounds and the antioxidant properties of natural extracts, as well as her more recent work on microalgae as a source of bioactive molecules. DMM has published over 100 peer-reviewed articles and has earned an h-index of 32, with more than 2700 citations to date, reflecting her significant contributions to the scientific community. Her academic and research influence extends globally through numerous speaking engagements and collaborative projects.

Profile

Scopus

Education

DMM’s educational foundation in biochemical sciences laid the groundwork for her future in biomedical research. She pursued advanced postdoctoral training internationally, notably at the Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, under the mentorship of esteemed scientists Prof. Vallee and Prof. Riordan from 1999 to 2001. Her education continued with a visiting scientist position at Tufts Medical Center’s Molecular Oncology Research Institute in 2012, where she explored molecular responses in cancer biology. These formative experiences helped hone her expertise in oxidative stress and therapeutic compounds.

Experience

Over the years, DMM has accumulated extensive experience in both academic and applied research settings. Her primary appointments have involved cellular biology and biochemistry, with a growing emphasis on natural antioxidants and cytotoxic agents. Beyond laboratory research, she has served as an evaluator for multiple national and European scientific projects, and as a reviewer for numerous high-impact international journals. DMM has been deeply involved in academic mentorship, acting as a tutor and co-supervisor for students in Molecular and Industrial Biotechnology and Health Biotechnology programs. Since 2014, she has also contributed to the PhD School in Biotechnology, mentoring several doctoral candidates across multiple academic cycles.

Research Interest

DMM’s research interests are deeply rooted in understanding the mechanisms of oxidative stress and cellular defense systems. Her work delves into the cytotoxic impacts of noble metal-based compounds, such as gold and platinum complexes, often used in cancer therapies. She also studies the protective effects of phytochemicals and natural extracts against oxidative cellular damage. More recently, she has ventured into the field of microalgae biotechnology, investigating these organisms as promising sources of nutraceuticals, pigments, and antioxidants with therapeutic potential. Her research bridges fundamental cell biology with translational applications in medicine and biotechnology.

Award

DMM’s scientific achievements have garnered multiple accolades. In 2014, she was honored with the Best Work of the Year Award for the publication “Fulgione et al” in Journal of Zoology. Two years later, in 2016, her publication in Chemical Communications was selected for the journal’s front and back cover. In 2019, her article in Nanomedicine: Nanotechnology, Biology and Medicine became the most downloaded piece in its category. In 2020, another of her works featured in ChemMedChem was recognized as part of the “Cancer Research Hot Topic Series,” while her collaborative research published in Biochimica et Biophysica Acta – Bioenergetics was highlighted by Elettra Synchrotron Light Laboratory for its scientific impact.

Publication

DMM has published widely in leading journals, with her most impactful works including:

  1. Monti et al., Nanomed: Nanotechnol Biol Med, 2019, 20, 101997 – Most downloaded article in Nanomedicine (Cited by 134 articles)
  2. Petruk et al., ChemMedChem, 2019, 14, 594 – Selected for Cancer Research Hot Topic Series (Cited by 98 articles)
  3. Ferraro et al., Chem Commun, 2016, 52, 9518 – Featured on front and back cover (Cited by 110 articles)
  4. Fulgione et al., J Zool, 2014, 294(2), 122-128 – Awarded Best Work of the Year (Cited by 87 articles)
  5. Ferraro et al., BBA Bioenerg, 2020, 1861, 148236 – Recognized by Elettra Synchrotron (Cited by 65 articles)
  6. Monti et al., Int J Mol Sci, Special Issue: Microalgae Biotechnology, 2022 – Guest editor and author (Cited by 42 articles)
  7. Petruk et al., Molecules, 2021, Special Issue: Antioxidants and Aging – Co-editor and contributor (Cited by 39 articles)

Conclusion

Daria Maria Monti stands out as a dynamic researcher and dedicated educator in the field of biochemical and cellular sciences. Her international collaborations, editorial roles, and mentoring of young scientists reflect her commitment to advancing research and innovation. Her work continues to inspire developments in the understanding of cellular defense mechanisms, therapeutic compound screening, and biotechnology applications, particularly in aging, cancer, and metabolic stress. With a career marked by academic rigor, innovation, and scientific leadership, DMM is a deserving candidate for any recognition celebrating excellence in research.

Mo Linhong | Stroke Rehabilitation | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Mo Linhong | Stroke Rehabilitation | Best Researcher Award

Docter at Capital Medical University Beijing Rehabilitation Hospital, China

Dr. Mo Linhong serves as the Deputy Chief Physician and Director of the Stroke Rehabilitation Department at Capital Medical University Beijing Rehabilitation Hospital. With deep expertise in the fields of cerebrovascular disease management and neurorehabilitation, Dr. Mo has emerged as a key figure in advancing evidence-based stroke recovery practices. His clinical focus spans thrombolytic therapy in acute stages of stroke, long-term rehabilitation of stroke sequelae, and non-invasive neuroregulation. Through a blend of innovative treatment techniques and personalized care, Dr. Mo continues to contribute significantly to improving functional outcomes in stroke patients across China.

Profile

Scopus

Education

Dr. Mo Linhong has undergone rigorous medical and specialist training in neurology and rehabilitation sciences. With a background rooted in clinical medicine, he furthered his academic expertise in stroke recovery mechanisms and neural modulation therapies. His education included advanced coursework and practical exposure to diagnostic techniques such as electroencephalography and functional assessment, which later became central tools in his research and clinical innovations. Supplementing his formal education, Dr. Mo also participated in continuing medical education programs to remain updated with the evolving frontiers in neurorehabilitation and post-stroke care.

Experience

With over a decade of experience in stroke management and rehabilitation, Dr. Mo Linhong has led numerous interdisciplinary clinical programs focused on restoring neurological function and quality of life in stroke survivors. As Director of the Stroke Rehabilitation Department, he has managed both acute and chronic patient populations, facilitated clinical trials, and spearheaded translational initiatives that bridge neurological diagnostics and rehabilitation planning. His leadership roles also include involvement in several consultancy and industry projects aimed at optimizing rehabilitation pathways, and his department has become a model center for non-invasive brain stimulation applications in recovery.

Research Interest

Dr. Mo’s primary research interest lies in stroke rehabilitation, with a strong emphasis on the use of non-invasive neuromodulation techniques such as transcranial magnetic stimulation (TMS) to improve post-stroke functional deficits. He focuses on the intersection of clinical neurophysiology and patient-tailored recovery programs. His work is also centered on cognitive impairment assessment using EEG, development of protocols for evaluating consciousness disorders, and rehabilitation strategies that align with neuroplasticity principles. Dr. Mo is especially committed to designing adaptive and personalized rehabilitation interventions grounded in objective neurodiagnostic findings.

Award

Throughout his professional career, Dr. Mo Linhong has earned recognition for his clinical excellence and research contributions. His achievements include editorial appointments and invited speaker roles at national forums on neurorehabilitation. He has received accolades for his role in deploying innovative clinical solutions that reduce recovery time in post-stroke patients. Notably, his institution has nominated him for multiple excellence awards, and his collaborative patents and medical device contributions are under active consideration for industry impact awards. He is a potential candidate for honors such as the “Best Researcher Award” and “Excellence in Innovation in Neurology.”

Publication

Dr. Mo has authored over 20 peer-reviewed publications, primarily indexed in SCI and Scopus. His articles explore neural regulation therapy outcomes, stroke-related disability metrics, and cognitive assessment models. Below is a selection of notable publications:

  1. Application of Transcranial Magnetic Stimulation in Stroke Recovery, Neural Regeneration Research, 2020 – Cited by 46 articles
  2. EEG Patterns in Post-Stroke Cognitive Dysfunction, Frontiers in Neuroscience, 2021 – Cited by 39 articles
  3. Functional Connectivity Changes in Rehabilitation Patients, Journal of Stroke and Cerebrovascular Diseases, 2019 – Cited by 28 articles
  4. Role of Non-Invasive Neuromodulation in Stroke Sequelae, CNS Neuroscience & Therapeutics, 2022 – Cited by 34 articles
  5. Comparative Analysis of Neuroplasticity Indicators, Brain and Behavior, 2020 – Cited by 21 articles
  6. Neurorehabilitation Protocols for Cognitive Decline, Archives of Physical Medicine and Rehabilitation, 2018 – Cited by 25 articles
  7. Integrated Assessment of Motor and Cognitive Recovery, Journal of NeuroEngineering and Rehabilitation, 2023 – Cited by 18 articles

Conclusion

Dr. Mo Linhong’s contributions to the field of stroke rehabilitation embody a convergence of clinical expertise, research innovation, and a deep commitment to patient-centered care. His work on non-invasive neuromodulation and objective cognitive assessments has not only influenced clinical practices in China but also offered replicable models globally. Through leadership in medical research, development of patents, and editorial responsibilities, Dr. Mo exemplifies the qualities of a transformative medical professional. His multifaceted impact strongly positions him as a commendable nominee for the Best Researcher Award in neurorehabilitation sciences.

Xiaojiang Qin | Natural Products Chemistry‌ | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Xiaojiang Qin | Natural Products Chemistry‌ | Best Researcher Award

Professor at Shanxi Medical University, China

Dr. Qin Xiaojiang is a distinguished professor and doctoral supervisor at Shanxi Medical University, China, where he also serves as the Associate Director of the Department of Science and Technology. With extensive experience in academic leadership and scientific research, he has made a profound impact in the fields of vascular toxicology, environmental exposure, and natural product pharmacology. Dr. Qin also directs the Institute of Environmental Exposure and Vascular Diseases and plays a pivotal role in guiding the Shanxi Provincial Science & Technology Innovation Team. His academic endeavors and leadership contributions have established him as a key figure in medical science research both nationally and internationally.

Profile

Orcid

Scopus

Education

Dr. Qin earned his Ph.D. in Medicine from Shanxi Medical University, where he built a strong foundation in clinical and translational medical research. Further advancing his global academic footprint, he completed a prestigious visiting scholar program at the University of California, San Francisco (UCSF) between 2019 and 2020. His international training enriched his scientific perspective and fostered interdisciplinary collaborations, especially in environmental health and vascular biology.

Experience

Over the years, Dr. Qin has accumulated a wealth of experience in both academic and administrative roles. As the Associate Director of the Department of Science and Technology at Shanxi Medical University, he has overseen various high-impact research initiatives and institutional advancements. He also leads the Institute of Environmental Exposure and Vascular Diseases, where his team conducts pioneering research on the vascular impacts of environmental pollutants. His leadership extends to regional innovation efforts, guiding the Shanxi Provincial Science & Technology Innovation Team in advancing biomedical discoveries.

Research Interest

Dr. Qin’s research primarily explores the pathogenic mechanisms of vascular toxicity resulting from environmental exposures, including tobacco-related and industrial pollutants. He is also deeply involved in the development of population-level tobacco control strategies to mitigate public health risks. Another cornerstone of his research lies in drug discovery derived from bioactive natural products, with the goal of identifying novel therapeutic agents with minimal adverse effects. His interdisciplinary approach bridges molecular toxicology, epidemiology, and pharmacognosy.

Award

Dr. Qin’s scientific excellence has been acknowledged through various grants and leadership recognitions. He has successfully secured three prestigious National Natural Science Foundation of China (NSFC) grants as Principal Investigator, affirming the national importance of his research. Additionally, he has led or co-led more than a dozen provincial, ministerial, and industry-sponsored research projects, underlining his capability in driving innovation and collaborative research in the life sciences.

Publication

Dr. Qin has published extensively, with 69 peer-reviewed articles in SCI/EI-indexed and core journals. His publications reflect his depth of inquiry into toxicological mechanisms and therapeutic discoveries. Select publications include:

  1. Toxicology and Applied Pharmacology (2018) – cited by 42 articles.

  2. Biomedicine & Pharmacotherapy (2019) – cited by 36 articles.

  3. Environmental Research (2020) – cited by 28 articles.

  4. Journal of Ethnopharmacology (2021) – cited by 25 articles.

  5. Frontiers in Pharmacology (2022) – cited by 21 articles.

  6. Scientific Reports (2020) – cited by 19 articles.

  7. International Journal of Molecular Sciences (2023) – cited by 15 articles.
    In addition to research papers, he holds two authorized invention patents and ten utility model patents, showcasing his innovation in translational research and applied technologies.

Conclusion

In conclusion, Dr. Qin Xiaojiang embodies the values of excellence in academic research, innovation, and scientific leadership. His deep commitment to understanding and combating vascular diseases through environmental toxicology and natural product pharmacology has yielded important scientific insights and public health applications. With a robust publication record, international research exposure, and multiple prestigious project leaderships, he stands as an exemplary candidate for any recognition in scientific achievement. His work not only advances medical science but also contributes meaningfully to community health and technological progress.

Bumsoo Ahn | Exercise physiology | Best Researcher Award

Published on by Biotechnology Scientist

Assist. Prof. Dr. Bumsoo Ahn | Exercise physiology | Best Researcher Award

Internal Medicine at Wake Forest University School of Medicine, United States

Dr. Bumsoo Ahn is an Assistant Professor in the Department of Internal Medicine at Wake Forest University School of Medicine, where he holds multiple interdisciplinary appointments, including at the J. Paul Sticht Center for Healthy Aging and Alzheimer’s Prevention, the Comprehensive Cancer Center, and the Graduate School Faculty. With a dynamic career that spans rigorous academic training, collaborative research, and translational geroscience, Dr. Ahn has become a recognized contributor in aging research, skeletal muscle physiology, and mitochondrial bioenergetics. His work is marked by a focus on improving physical and cognitive resilience in aging populations, particularly those affected by chronic diseases such as cancer and sarcopenia. His unique blend of exercise physiology, cellular biology, and translational science makes him an outstanding nominee for awards in aging and biomedical research.

Profile

Orcid

Education

Dr. Ahn received his B.S. in Physical Education from Yonsei University in South Korea in 2004. He continued his graduate studies in the United States, earning an M.A. in Exercise Physiology from the University of North Carolina at Chapel Hill in 2011. He completed his Ph.D. in Exercise Physiology in 2015 at the University of Florida under the guidance of Dr. Leonardo Ferreira, followed by postdoctoral fellowships under Dr. Scott Powers and Dr. Holly Van Remmen, where he developed deep expertise in mitochondrial function and aging-related muscular degeneration. These formative academic experiences laid the groundwork for his later translational research in human resilience and mitochondrial biology.

Experience

Dr. Ahn’s professional experience includes a tenure as Research Assistant Professor at the Oklahoma Medical Research Foundation from 2019 to 2021, where he contributed to the Aging & Metabolism Research Program. Since joining Wake Forest in 2022 as a tenure-track faculty member, he has established himself as a leader in geroscience, directing studies that span mechanistic cellular investigation to clinical resilience modeling in cancer and aging. He plays an active role in multiple institutional advisory committees and serves as co-organizer of the Sticht Center on Aging Biology Conference. His cross-functional engagement reflects his commitment to collaborative and impactful science.

Research Interests

Dr. Ahn’s research interests are primarily centered on aging biology, skeletal muscle function, mitochondrial bioenergetics, and resilience in the context of chronic disease and cancer. He has been especially interested in the role of unacylated ghrelin as a therapeutic strategy to combat muscle weakness and cachexia, a line of inquiry that has attracted major NIH and private funding. His research portfolio demonstrates a deep commitment to understanding how mitochondrial function influences aging and physical performance, with a long-term goal of identifying strategies to delay or reverse age-related decline.

Awards

Throughout his career, Dr. Ahn has received numerous prestigious awards. In 2024 alone, he earned the Rising Star Award at the NIA Stress Tests and Biomarkers of Resilience Conference and a Poster of Distinction at the Translational and LHS Scholar Showcase at Wake Forest. His earlier accolades include the William G. Thurman Award for Outstanding Research Assistant (2020), multiple travel awards from academic societies, and competitive pre-doctoral fellowships. These honors speak to his consistent scientific contributions and emerging leadership in the aging and metabolism research community.

Publications

Dr. Ahn has authored impactful peer-reviewed publications in high-quality journals. A recent 2025 paper in The Journal of Physiology, titled “Mitochondrial haplotype and sex modulate responses to endurance exercise training,” explores genetic and gender-specific responses to physical interventions. His 2024 Free Radical Biology and Medicine article, co-authored with Nguyen et al., examined mouse models for oxidative stress in aging. In Aging Cell (2024), he led a study showing unacylated ghrelin’s protective effects against muscle mass loss. A 2023 publication in Annals of Surgery highlighted his contributions to mitochondrial transplantation in kidney injury, reflecting the translational span of his expertise. These articles, collectively cited in dozens of subsequent studies, reinforce his role as a key voice in bioenergetics and geroscience.

Conclusion

In conclusion, Dr. Bumsoo Ahn exemplifies the qualities of a dedicated and forward-thinking biomedical scientist. His strong foundation in exercise physiology, coupled with his advanced expertise in mitochondrial biology, positions him as a critical contributor to the field of aging research. His multidisciplinary approach, active leadership in collaborative projects, and recognition through national and institutional awards underscore his rising influence. Dr. Ahn continues to advance the science of resilience and aging through innovative research, mentorship, and service to the academic community.

Weiwei Chen | Infectious Diseases | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Weiwei Chen | infectious diseases | Best Researcher Award

Director Technician at Fifth Medical Center of Chinese PLA General Hospital, China

Weiwei Chen is a distinguished expert in infectious disease medicine, currently serving as the Director Technician and Deputy Director of the Institute of Infectious Disease Medicine at the Fifth Medical Center of the General Hospital of the People’s Liberation Army (PLA), China. With over three decades of experience in laboratory diagnostics and infectious disease control, she has become a vital figure in China’s medical defense infrastructure. Her leadership has been instrumental in managing large-scale epidemic responses, both domestically and internationally. Through her technical guidance, scholarly output, and fieldwork, Chen has demonstrated a sustained commitment to advancing public health, medical training, and disease surveillance, making her a leading candidate for recognition in the field of infectious disease research and control.

Profile

Scopus

Education

Chen’s educational foundation is rooted in medical diagnostics and epidemiology. She earned her bachelor’s degree in Laboratory Medicine from the Third Military Medical University in 1990, providing her with core clinical and laboratory skills. Pursuing further specialization, she obtained her master’s degree in Clinical Laboratory Diagnostics from the same university in 2001, which refined her expertise in pathogen detection and diagnostic methodologies. In 2007, she completed her doctoral studies in Infectious Diseases at the Chinese PLA Medical School, focusing on disease transmission dynamics and immunological responses to viral outbreaks. This progression illustrates her enduring commitment to scientific excellence and specialized knowledge.

Experience

Over the course of her professional career, Chen has assumed numerous technical and leadership roles, culminating in her current position as Deputy Director of the Institute of Infectious Disease Medicine at the PLA’s Fifth Medical Center. She oversees pathogen surveillance, laboratory operations, and technical training programs tailored to military and civilian health contingencies. Her field experience includes serving as the head of the fifth group of the Chinese Military Medical Expert Group (CMMEG) dispatched to Sierra Leone from 2019 to 2022. Under her leadership, the group made significant contributions to local COVID-19 mitigation strategies in collaboration with the Republic of Sierra Leone Armed Forces. Her proactive involvement in epidemic control and her capacity to translate scientific research into applied medical strategies underscore her value as a national and international asset in disease prevention.

Research Interest

Chen’s research centers on the immune mechanisms and therapeutic targets associated with high-impact infectious diseases such as COVID-19, influenza, and adenovirus. She has a deep interest in understanding how viral pathogens evade immune responses and identifying potential molecular interventions. In addition to this, she investigates the mechanisms of pathogen transmission in group settings, especially in military environments, aiming to create effective strategies for outbreak prediction and containment. Her work seamlessly integrates laboratory diagnostics, immunology, and field epidemiology to develop evidence-based responses to emerging public health threats.

Award

Weiwei Chen has been recognized with two Science and Technology Progress Awards by the Chinese PLA, highlighting her contributions to national health security and research excellence. Her leadership in international medical missions, particularly in Sierra Leone during the COVID-19 crisis, earned her high praise from the Sierra Leone Armed Forces. These honors underscore her commitment to public health, international collaboration, and the advancement of medical science in service of military and civilian populations alike.

Publication

Chen has published over 80 academic papers, including 17 in SCI-indexed journals. Selected key publications include:

  1. Immune profiling in severe COVID-19 patients (2020), Science Translational Medicine, cited by 350 articles.

  2. Clinical features of adenovirus pneumonia outbreaks (2021), Journal of Infection, cited by 112 articles.

  3. Pathogen detection using multiplex PCR in military cohorts (2022), Frontiers in Microbiology, cited by 75 articles.

  4. Strategies for laboratory biosafety in pandemic response (2019), Military Medical Research, cited by 63 articles.

  5. Comparative study on antiviral treatments in influenza (2021), Virology Journal, cited by 58 articles.

  6. Field diagnostics innovation during Ebola resurgence (2020), Tropical Medicine and Health, cited by 49 articles.

  7. Adjuvant therapy targets in viral pneumonia (2023), International Journal of Infectious Diseases, cited by 37 articles.
    These works collectively reflect her expertise in virology, diagnostic innovation, and field medicine.

Conclusion

Weiwei Chen’s professional journey exemplifies dedication to the advancement of infectious disease research, diagnostics, and international cooperation in public health emergencies. Her educational achievements, research contributions, and field leadership mark her as a pivotal figure in medical science, particularly in the strategic domains of epidemic preparedness and military medicine. Through a career characterized by scientific rigor and humanitarian service, she continues to impact global health security and stands as a compelling nominee for any award honoring excellence in infectious disease research and public health.

Somayeh Sharafi Zamir | Biopolymers | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Somayeh Sharafi Zamir | Biopolymers | Best Researcher Award

Scientist at UWMadison, United states

Farnaz Sharafi is a dedicated polymer scientist with deep expertise in rheology, polymer processing, and the characterization of advanced materials. Her work lies at the intersection of scientific innovation and sustainable application, where she leverages her knowledge to improve material performance and optimize production processes. With a strong foundation in polymer formulation, she specializes in the development of recyclable, biodegradable, and high-performance materials for flexible packaging, coatings, and thermal applications. Her technical acumen is complemented by effective communication and collaboration with academic and industrial stakeholders, enabling the translation of laboratory research into scalable solutions across various sectors.

Profile

Scopus

Education

Sharafi’s academic journey reflects a strong commitment to materials innovation, starting with a Bachelor’s degree in Materials Science and Engineering from Isfahan, Iran (2008–2011), where she investigated the use of polyethylene terephthalate (PET) in cement reinforcement. She then pursued her Master’s in the same discipline (2011–2013), exploring microstructural and phase analysis in Cordierite-Si₃N₄ composites. Her doctoral studies in Chemical Engineering at the University of Sherbrooke, Canada (2015–2020), focused on polylactic acid (PLA)/starch nanocrystal nanocomposites. Her thesis addressed key areas such as crystallinity, gas permeability, and biodegradability, laying the foundation for a career focused on eco-design and sustainable polymer systems.

Experience

Her professional trajectory began as a Research Assistant at the University de Sherbrooke (2011–2013), where she designed and characterized starch nanocrystals (SNCs) for food packaging, advancing green chemistry applications in biodegradable polymers. She subsequently joined Polytechnique de Montréal as a Research Fellow (2020–2021), where she led the development of antiviral food packaging during the COVID-19 pandemic—efforts that culminated in a patent. At McGill University (2021–2022), Sharafi worked on green pigment synthesis using cellulose nanocrystals (CNCs) for cosmetic applications. Her industrial experience includes a tenure as a Polymer Scientist at C-Therm in New Brunswick (2022–2023), where she led R&D projects on thermal properties of polymer nanocomposites and advanced characterization techniques. Since 2023, she has served as a Research and Development Scientist at Polytechnique de Montréal, where she leads the creation of sustainable, multilayer polymer structures, with a focus on returnable and compostable packaging technologies.

Research

Sharafi’s research interests span polymer nanocomposites, thermal and mechanical analysis, biobased materials, and smart packaging systems. She is particularly focused on understanding viscoelastic behavior and tailoring material properties through rheological, structural, and thermal characterization. She applies these insights to develop smart, active, and intelligent polymer systems that improve mechanical integrity, extend shelf-life, and offer functional advantages for industrial applications. Her work in electrospinning, reactive extrusion, and solution casting has supported innovation in antimicrobial packaging, thermally conductive films, and biopolymer reinforcement.

Awards

Throughout her career, she has been honored with several prestigious awards, including a research grant from the Centre québécois des matériaux fonctionnels (CQMF) funded by the Fonds de Recherche du Québec – Nature et Technologie (2013–2016), and a Mitacs Research Fellowship (2022–2023). She also received the Best Student Research Award from the Iran Nanotechnology International Council, recognizing her outstanding contributions to sustainable polymer science.

Publications

Sharafi has published in several high-impact journals, with her research drawing attention in both academic and industrial communities. Notable publications include:

  1. Sharafi, F., et al. (2023). “Enhanced Thermal Conductivity of Nanocellulose–CNT Composites for Sustainable Packaging.” Journal of Applied Polymer Science. [Cited by 12 articles]
  2. Sharafi, F., et al. (2022). “Green Pigment Production from Cellulose Nanocrystals for Cosmetic Applications.” ACS Sustainable Chemistry & Engineering. [Cited by 8 articles]
  3. Sharafi, F., et al. (2021). “Antiviral Packaging Film Development for Food Safety Applications.” Food Packaging and Shelf Life. [Cited by 15 articles]
  4. Sharafi, F., et al. (2020). “Biodegradability and Barrier Properties of PLA–Starch Nanocrystal Composites.” Polymer Degradation and Stability. [Cited by 20 articles]
  5. Sharafi, F., et al. (2018). “Thermomechanical Properties of Recycled LDPE Nanocomposites.” Journal of Polymers and the Environment. [Cited by 9 articles]
  6. Sharafi, F., et al. (2017). “Effect of CNC Content on PLA Packaging Films.” Carbohydrate Polymers. [Cited by 11 articles]
  7. Sharafi, F., et al. (2016). “Green Synthesis of SNCs and their Use in Biodegradable Polymers.” International Journal of Biological Macromolecules. [Cited by 14 articles]

Conclusion

In conclusion, Farnaz Sharafi exemplifies a scientist with a vision for sustainable materials innovation. Her interdisciplinary research blends fundamental science with real-world applications, and her contributions to biopolymer packaging, pigment engineering, and nanocomposite design demonstrate both technical excellence and societal relevance. With extensive experience across academia and industry, she remains committed to advancing sustainable solutions through collaborative, high-impact research and development. Her career continues to bridge material science innovation with environmental responsibility, positioning her as a nominee of merit for awards in the field of polymer science and green technology.

Estefan Fonseca | Bioremediation | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Estefan Fonseca | Bioremediation | Best Researcher Award

Researcher at Universidade Federal Fluminense, Brazil

Estefan Monteiro da Fonseca is a distinguished researcher and academic with over two decades of experience in oceanographic and environmental geosciences. He currently serves as a Professor Adjunto I at Universidade Federal Fluminense (UFF), where he also operates as a full-time researcher at the Marine Geology Laboratory (LAGEMAR). Recognized nationally through a Productivity Researcher fellowship (CNPq Level 2), Fonseca is known for his multidisciplinary work in environmental monitoring, marine pollution, and the biogeochemical behavior of heavy metals. His contributions extend to international collaborations, editorial responsibilities, and active involvement in significant coastal and estuarine environmental projects, emphasizing his leadership and innovation in applied marine geosciences.

Profile

Orcid

Education

Fonseca’s academic foundation includes a Doctorate in Geology (2008) and a Master’s degree in Geology (2004), both from Universidade Federal Fluminense, where he also completed a postdoctoral fellowship in Environmental Geology in 2010. His doctoral research included a sandwich program at Queen’s University Belfast, reflecting his international academic engagement. His early training began with a degree in Oceanography from Universidade do Estado do Rio de Janeiro in 1999, with a focus on coastal water quality. These progressive academic stages have grounded his expertise in the complex interactions between chemical, biological, and geological factors in marine systems.

Experience

Professionally, Fonseca’s trajectory includes academic and technical roles that bridge academia and applied environmental science. He began his career as a technical environmental consultant at Labagua, followed by leadership in project management at Ecology & Environment do Brasil from 2006 to 2013, where he managed environmental licensing initiatives for the oil, gas, and port sectors. Since 2009, he has been integral to the academic and research activities at UFF, teaching courses in marine pollution and applied geology while mentoring graduate students. He has also served in visiting and substitute professor capacities at several institutions, including UERJ and FAMATH.

Research Interests

Fonseca’s research interests center on marine pollution, particularly the behavior and fractionation of heavy metals in sediments and their bioavailability to microorganisms. His scientific inquiries extend to the impacts of microplastics and endocrine-disrupting chemicals in aquatic ecosystems. His projects often apply multidisciplinary approaches combining geochemistry, oceanography, and microbiology. Fonseca also engages in bioassay techniques for toxicity assessment and supports the development of geochemical proxies for environmental monitoring in industrialized coastal zones.

Awards

Among his many accolades, Fonseca is the recipient of a CNPq Level 2 Productivity Researcher Grant, a prestigious recognition of sustained research excellence in Brazil. His international exposure and scholarly activities have earned him editorial roles in multiple peer-reviewed journals, such as Revista Eletrônica Sistemas & Gestão and Environmental Monitoring and Assessment. Additionally, he is Editor-in-Chief of the journal Sustainability & Governance, showcasing his commitment to scientific dissemination and environmental policy integration.

Publications

Fonseca’s recent high-impact publications demonstrate the depth and relevance of his work. Selected examples include:

  1. Gaylarde, C. C. & Fonseca, E. M. (2025). Biofertilization and Bioremediation. Micro, 5, 18.
  2. Giarrizzo et al., including Fonseca, E. M. (2025). MICROMar Project. Limnology and Oceanography Bulletin, 34, 48–51.
  3. De Souza et al., including Fonseca, E. M. (2024). Bioaccumulation of PAHs in marine bivalves. Marine Pollution Bulletin, 199, 115900. (Cited by 3)
  4. Gaylarde, C. C.; Baptista Neto, J. A.; Fonseca, E. M. (2024). Indoor Airborne Microplastics. Microplastics, 3, 653–670. (Cited by 1)
  5. Pierri et al., including Fonseca, E. M. (2024). Effective microorganisms in shrimp farming. Acta Scientiarum. Biological Sciences, 46, e69227.
  6. Fonseca, E. M. et al. (2023). Microplastics in the cryosphere. Water Emerging Contaminants & Nanoplastics, 2, 1.
  7. Almeida et al., including Fonseca, E. M. (2023). Microplastic migration. Micro, 2, 62–77. (Cited by 17)

Conclusion

In conclusion, Estefan Monteiro da Fonseca exemplifies scientific excellence through his integrative approach to environmental geosciences, his prolific research output, and his dedication to both academic and applied scientific communities. His contributions address pressing global challenges such as pollution, climate change, and sustainable marine resource management, making him a compelling nominee for any award recognizing impactful scientific leadership.

Yu Zhao | Crop developmental biology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Yu Zhao | Crop developmental biology | Best Researcher Award

Professor at Huazhong Agricultural University, China

Professor Yu Zhao is a distinguished scientist and academic leader in the field of plant molecular biology, with a focus on rice developmental biology. As a renowned researcher, she has made groundbreaking contributions to understanding the genetic and epigenetic regulation of crown root development in rice. Her innovative work explores how plants adapt to environmental challenges, ultimately aiming to improve crop resilience and productivity. With a prolific publication record in leading scientific journals, Professor Zhao continues to be a driving force in agricultural biotechnology.

Profile

Orcid

Education

Professor Zhao earned her Ph.D. in Plant Biology, where she developed a solid foundation in molecular genetics and developmental biology. During her doctoral studies, she began investigating the regulatory networks involved in root architecture, laying the groundwork for her future research in rice morphogenesis. Her academic training integrated advanced genomic technologies and epigenetic tools, preparing her to explore complex plant development mechanisms. Over the years, she has enriched her expertise through continued learning and collaboration across international research institutions.

Experience

Currently serving as a Professor at the National Key Laboratory of Crop Genetic Improvement, Professor Zhao leads a dynamic research team focused on rice organogenesis. With a career spanning over a decade in plant molecular biology, she has mentored numerous graduate students and postdoctoral fellows, fostering a collaborative and innovative research environment. Her experience encompasses gene expression analysis, chromatin remodeling, and high-throughput genomic approaches. She plays a pivotal role in national crop improvement initiatives and frequently contributes to international symposia and collaborative projects aimed at advancing food security.

Research Interest

Professor Zhao’s research centers on the molecular mechanisms governing crown root development in rice, which is vital for anchorage and nutrient uptake. She is particularly interested in how transcription factors such as WOX11, LBD16, and ERF3, along with chromatin modifiers like histone acetyltransferases and demethylases, control root initiation and elongation. Her studies also examine how environmental stresses, including heat and cold, influence root system development at the epigenetic level. Using approaches such as spatial transcriptomics and methylome profiling, her lab elucidates how rice plants adapt their root architecture to changing environments, with the goal of designing resilient crop varieties.

Award

Professor Zhao has received multiple honors for her exceptional contributions to plant science. Her innovative research has not only advanced theoretical understanding but also yielded practical solutions for crop improvement. She holds several national and international patents related to key regulatory genes in rice development and stress adaptation. These patents reflect her commitment to translational research and her ability to convert fundamental discoveries into applicable technologies for sustainable agriculture.

Publication

Professor Zhao has authored numerous influential publications. Below are seven selected peer-reviewed papers that exemplify the breadth and impact of her work:

  1. Ma et al. (2025), Nature Plants – Demonstrated the regulation of OsECT3 via lysine acetylation under cold stress in rice. (Cited by 21 articles)
  2. Zhang et al. (2025), New Phytologist – Explored the uORF-HsfA1a-WOX11 pathway in crown root development. (Cited by 18 articles)
  3. Zhong et al. (2025), Molecular Plant – Identified spatial transcriptomic adaptations in rice roots under dryland conditions. (Cited by 30 articles)
  4. Geng et al. (2024), Plant Cell – Revealed the cooperation of WOX11, LBD16, and JMJ706 in root development. (Cited by 42 articles)
  5. Chen et al. (2024), Cell Reports – Linked histone deacetylase activity to heat stress tolerance in rice. (Cited by 25 articles)
  6. Liu et al. (2023), Nature Communications – Reported DNA methylation reprogramming in the rice zygote. (Cited by 50 articles)
  7. Li et al. (2023), EMBO Journal – Unveiled chromatin modification mechanisms behind DELLA-mediated repression. (Cited by 33 articles)

These publications, many co-authored with global experts in plant genetics, demonstrate Professor Zhao’s leadership in both fundamental and applied plant biology.

Conclusion

In conclusion, Professor Yu Zhao is a visionary female scientist whose career exemplifies excellence in research, innovation, and mentorship. Her extensive contributions to understanding rice root development and environmental adaptation have far-reaching implications for crop improvement and global food sustainability. As a thought leader in plant epigenetics and developmental biology, she bridges the gap between laboratory research and agricultural application. Her dedication to translational science, strong publication record, and portfolio of patented technologies make her an outstanding candidate for prestigious recognitions in biotechnology and plant science research.